586 related articles for article (PubMed ID: 15918040)
1. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
4. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
[TBL] [Abstract][Full Text] [Related]
5. [The association of expression and gene polymorphism of the thymidylate synthase gene with 5-fluoro-5'-deoxyuridine sensitivity in gastric cancer cell lines].
Kaneko M; Kawakami K; Oyama K; Endo Y; Tanaka M; Sasaki T; Watanabe G
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1347-50. PubMed ID: 15446554
[TBL] [Abstract][Full Text] [Related]
6. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
[TBL] [Abstract][Full Text] [Related]
7. A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele.
Gusella M; Bolzonella C; Crepaldi G; Ferrazzi E; Padrini R
Pharmacogenomics J; 2006; 6(6):421-4. PubMed ID: 16868573
[TBL] [Abstract][Full Text] [Related]
8. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
Kawakami K; Omura K; Kanehira E; Watanabe Y
Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
Kawakami K; Watanabe G
Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
[TBL] [Abstract][Full Text] [Related]
11. A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.
Mandola MV; Stoehlmacher J; Muller-Weeks S; Cesarone G; Yu MC; Lenz HJ; Ladner RD
Cancer Res; 2003 Jun; 63(11):2898-904. PubMed ID: 12782596
[TBL] [Abstract][Full Text] [Related]
12. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
Kiss-László Z; Nagy B; Thurzó L; Szabó J
Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
[TBL] [Abstract][Full Text] [Related]
13. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
[TBL] [Abstract][Full Text] [Related]
14. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy.
Yhim HY; Cho SH; Kim SY; Cho IS; Lee KT; Lee WS; Lee SI; Park MR; Park SG; Han HS; Choi YS; Chung IJ; Shim HJ; Lee NR; Song EK; Kim HS; Yim CY
Oncol Rep; 2015 Jul; 34(1):155-64. PubMed ID: 25955097
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
Meulendijks D; Jacobs BA; Aliev A; Pluim D; van Werkhoven E; Deenen MJ; Beijnen JH; Cats A; Schellens JH
Int J Cancer; 2016 Jan; 138(1):245-53. PubMed ID: 26189437
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma].
Dong ZM; Cui YJ; Kuang G; Wang R; Yu FL; Zhang JH
Ai Zheng; 2005 Oct; 24(10):1225-9. PubMed ID: 16219137
[TBL] [Abstract][Full Text] [Related]
18. Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo.
de Bock CE; Garg MB; Scott N; Sakoff JA; Scorgie FE; Ackland SP; Lincz LF
Pharmacogenomics J; 2011 Aug; 11(4):307-14. PubMed ID: 20531375
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
Iacopetta B; Grieu F; Joseph D; Elsaleh H
Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
Stoehlmacher J; Goekkurt E; Mogck U; Aust DE; Kramer M; Baretton GB; Liersch T; Ehninger G; Jakob C
Cancer Lett; 2008 Dec; 272(2):221-5. PubMed ID: 18722050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]